Investigating the effect of budesonide nebulizer on healing and treatment process of children with pneumonia aged 1month to 5 years: a randomized clinical trial
Phase 3
Recruiting
- Conditions
- community acquired pneumonia.
- Registration Number
- IRCT20240204060891N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
age between 1 month to 5 years
community acquired pneumonia diagnosed by pediatrician
Informed consent of the child's family to enter the study
Observing and recording complete symptoms of patient during treatment
Exclusion Criteria
Metabolic disorder
cardiovascular disorder
hyper reactive airway disease
coagulopathy
psychological disorder
diabetes
Immunocompromised patients
Discontinuation of standard treatment for any possible reason
Reluctance to continue treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Average score of PRESS. Timepoint: Measuring the PRESS score before the study, on days 1, 2, 3, 4, and 5 and after the end of the trial. Method of measurement: Pediatric Respiratory Severity Score (PRESS).
- Secondary Outcome Measures
Name Time Method